Alan Rubino
Direttore/Membro del Consiglio presso VERICEL CORPORATION
Patrimonio netto: 1 M $ in data 30/04/2024
Posizioni attive di Alan Rubino
Società | Posizione | Inizio | Fine |
---|---|---|---|
VERICEL CORPORATION | Direttore/Membro del Consiglio | 28/09/2005 | - |
Independent Dir/Board Member | 28/09/2005 | - | |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Direttore/Membro del Consiglio | 01/05/2010 | - |
HealthCare Institute of New Jersey | Direttore/Membro del Consiglio | - | - |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Presidente | 16/08/2021 | - |
Storia della carriera di Alan Rubino
Precedenti posizioni note di Alan Rubino
Società | Posizione | Inizio | Fine |
---|---|---|---|
SANUWAVE HEALTH, INC. | Direttore/Membro del Consiglio | 01/09/2003 | 03/06/2021 |
Independent Dir/Board Member | 01/09/2003 | 03/06/2021 | |
RENOVACARE, INC. | Direttore/Membro del Consiglio | 15/11/2019 | 01/10/2020 |
Amministratore Delegato | 15/11/2019 | 25/03/2021 | |
Presidente | 01/10/2020 | 25/03/2021 | |
Presidente | 15/11/2019 | 25/03/2021 | |
EMISPHERE TECHNOLOGIES, INC. | Direttore/Membro del Consiglio | 13/09/2012 | 15/10/2019 |
Amministratore Delegato | 13/09/2012 | 15/10/2019 | |
Presidente | 13/09/2012 | 15/10/2019 | |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ. | Amministratore Delegato | 01/10/2010 | 01/07/2012 |
Fondatore | 01/10/2010 | 01/07/2012 | |
Presidente | 01/10/2010 | 01/07/2012 | |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Amministratore Delegato | 01/02/2008 | 01/09/2010 |
Fondatore | 01/01/2007 | 01/09/2010 | |
Presidente | 01/02/2008 | 01/09/2010 | |
░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Alan Rubino
Rutgers State University of New Jersey | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 15 |
Regno Unito | 2 |
Canada | 2 |
Posizioni
Director/Board Member | 8 |
President | 5 |
Chief Executive Officer | 4 |
Settori
Health Technology | 12 |
Consumer Services | 3 |
Electronic Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 5 |
---|---|
VERICEL CORPORATION | Health Technology |
W WORL | Health Technology |
INTERPACE BIOSCIENCES, INC. | Health Technology |
SANUWAVE HEALTH, INC. | Health Technology |
RENOVACARE, INC. | Health Technology |
Aziende private | 9 |
---|---|
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ. | Health Technology |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | Health Technology |
Emisphere Technologies, Inc.
Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Electronic Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
HealthCare Institute of New Jersey | |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
Hoffmann-La Roche Ltd.
Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Hoffmann-La Roche Ltd. is a Canadian pharmaceutical company that manufactures drugs. The company is based in Mississauga, Canada. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Alan Rubino
- Esperienza